Autosomal Dominant Polycystic Kidney Disease

Area of Science:

• Nephrology
• Genetics
• Internal Medicine

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) affects over 50% of individuals, leading to kidney failure and ranking as the 4th cause of end-stage kidney disease.
• ADPKD is a systemic disorder impacting kidneys, liver, heart, and vasculature, with potential severe complications like massive hepatomegaly or intracranial aneurysm rupture.

Purpose of the Study:

• To review current knowledge on ADPKD diagnosis and risk stratification for kidney failure.
• To discuss advancements in ADPKD treatment, including personalized medicine approaches.
• To cover essential management aspects such as blood pressure control and preimplantation genetic testing.

Main Methods:

• Literature review of recent advances in ADPKD genetics, prognosis, and treatment.
• Synthesis of information on diagnostic criteria and risk assessment tools for ADPKD.
• Compilation of current therapeutic strategies and management guidelines for ADPKD.

Main Results:

• Personalized treatment strategies are emerging, capable of modifying the natural history of ADPKD.
• Accurate diagnosis and risk stratification are crucial for effective ADPKD management.
• Comprehensive management includes blood pressure control and consideration of genetic testing.

Conclusions:

• Recent breakthroughs in ADPKD research enable personalized interventions to improve patient outcomes.
• Effective management of ADPKD requires a multidisciplinary approach focusing on early diagnosis, risk assessment, and tailored treatments.
• Ongoing research continues to refine treatment options and genetic testing for ADPKD patients.